Lupin has 11 manufacturing facilities, including two in Japan. It has seven formulations, out of which three are USFDA approved, and four APIs, out of which two are USFDA approved. Lupin is amongst the largest pharma companies in domestic market with net sales in excess of `17000 Crore.
Lupin is not only a global leader in anti-tuberculosis (TB) and other infectious diseases but also one of the fastest growing prescription companies in the US.
Lupin is currently developing complex products in areas such as opthalmology, respiratory, controlled substances, dermatology and biosimilars.
Established in 1968, Lupin has over time emerged as a leading Indian generic exporter. During these years, Lupin changed focus in therapies - from acute to chronic, while tapping overseas markets at the same time. Lupin received USFDA approvals for its two facilities Ankaleshwar and Mandideep way back in 1989.
Lupin has 11 manufacturing facilities, including two in Japan. It has seven formulations, out of which three are USFDA approved, and four APIs, out of which two are USFDA approved.
Lupin is amongst the largest pharma companies in domestic market with net sales in excess of ₹17000 Crore. The company has a strong brand portfolio, with R&D costs in excess of 13 per cent of sales. Exports for Lupin account for almost 73 per cent, with developed markets (DMs) contributing the most to the overall exports. DMs contribute almost 58 per cent to the total exports, whereas emerging markets (EMs) contribute 15 per cent to the total exports of Lupin. As far as sales mix goes, Lupin generates 10 per cent from APIs and domestic formulations –25 per cent, DM formulations – 56 per cent and EM formulations – 9 per cent.
FINANCIALS
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
How To Invest In An Ageing Bull Market
Bull rallies (periods when stock prices rise) and bear declines (periods when stock prices fall) are natural parts of stock market cycles, but they don't follow a fixed timeline.
Should You Entrust All Your Money To A Single AMC?
If you are a market participant, you have probably heard the quote 'don't put all your eggs in one basket', which suggests diversification. Investors often focus on diversifying across categories like large-cap, mid-cap and small-cap, but they may unintentionally overlook diversification across different AMCs. The question arises: is AMC-wise diversification really necessary? Rakesh Deshmukh takes a closer look at this scenario
Wild Swings Engulf Global Equities
U.S. stock markets experienced significant volatility. An early-week rally pushed the markets to new highs, but this momentum faded, primarily due to weaknesses in the tech sector. The major indices had a mixed finish with, S&P 500 and Nasdaq closed lower, while the Dow recorded a notable gain.
U.S. Elections and China's Economy Hamper Commodities
Commodity markets experienced selling pressure in the last fortnight, driven by uncertainties surrounding the upcoming U.S. presidential elections, concerns about the Chinese economy, and increased agricultural production in Brazil.
Wealth Building For Retirement Through Mutual Funds
Retirement is one of the most crucial and lifechanging phases. It marks a period where maintaining your lifestyle becomes paramount even though your regular income stops.
Mastering Investment with Information Ratio
Information Ratio helps in navigating the complexities of the investment landscape by assessing an active fund manager's performance. And though it has its limitations, it remains an essential part of the finance industry. The article explains what Information Ratio is and how investors can use it as another tool
Plan To Be Financially Independent
Each of us aspires to be financially independent as it ensures having enough resources to be self-sufficient and control our finances.
❝Technology is the new game-changer"
With a new breed of young investors entering the financial markets, it is the use of technology that is increasingly playing a major role in how investments are done and tracked. Anand Radhakrishnan, Managing Director, Sundaram Mutual Fund, shares his opinion about how this factor is turning into a significant tool and how it will shape the strategies of his company
What If Donald Trumps?
The potential election of Donald Trump as president in the U.S. carries significant implications for the Indian equity market. It could lead to changes in the global trade dynamics, in particular affecting the Indian IT sector while also raising inflation levels and leading to yet another revision in the visa programme for Indians who want to work in the US. The article takes a closer look at what may lie in store
Sectoral Gains Make A Mark
Benchmark indices continued their uptrend, reaching new record highs, although the pace has slowed as the broader markets faced selling pressures
